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Ethnopharmacological relevance: The 3b, 6b, 16b-trihydroxylup-20(29)-ene (TTHL) is a pentacyclic
triterpene obtained from a medicinal plant named Combretum leprosum. In folk medicine, this plant is
used to treat several diseases associated with inﬂammation and pain. We previously demonstrated that
TTHL presents a signiﬁcant antinociceptive effect, suggesting the involvement of the glutamatergic
system.
Aim of the study: This study was designed to investigate the effect of TTHL on nociception and vascular
permeability induced by acetic acid. We also evaluated the effect of TTHL on carrageenan-induced
peritonitis and the levels of cytokines (interleukin 1-b [IL-1b], tumor necrosis factor a [TNF-a] and
interleukin 10 [IL-10]) on peritoneal ﬂuid.
Materials and methods: TTHL was administered orally by intra-gastric gavage (i.g.) 60 min prior to
experimentation. Abdominal contractions and vascular permeability were induced by an intraperito-
neal (i.p.) injection of acetic acid (0.6%). We also investigated whether TTHL decreases carrageenan-
induced peritonitis (750 mg/cavity) by measuring leukocyte migration and vascular permeability.
In addition, we evaluated the effects of TTHL on TNF-a, IL-1b and IL-10 release induced by carrageenan
on peritoneal ﬂuid. The levels of these cytokines were measured by ELISA.
Results: TTHL (0.01–10 mg/kg) administered by intra-gastric (i.g.) gavage inhibited (6973%) acetic
acid-induced abdominal constrictions, with an ID50 of 0.15 (0.03–0.8) mg/kg. TTHL (10 mg/kg) also
reduced the leukocyte inﬁltration induced by acetic acid, with an inhibition of 5979 but had no effect
on abdominal vascular permeability. In addition, indomethacin (10 mg/kg, i.p.) reduced the nociceptive
behavior (9271%), total leukocyte migration (2973%) and capillary permeability (7173%) induced by
acetic acid. While the glucocorticoid dexamethasone (2 mg/kg, s.c.) reduced partially but signiﬁcantly
the nociception (3171%), besides to promote a marked reduction on total leukocyte migration
(6072%) to the peritoneal cavity caused by acetic acid. In a model of peritonitis induced by
carrageenan, TTHL also reduced total leukocyte migration, mainly neutrophils (inhibition of 8473%
and 8572% at 30 mg/kg and 100 mg/kg, respectively). Likewise, dexamethasone (0.5 mg/kg, i.p.)
resulted in an inhibition of 9373%. Nevertheless, carrageenan-induced abdominal vascular perme-
ability was reduced by dexamethasone but was not altered by TTHL. Furthermore, dexamethasone and
TTHL signiﬁcantly reduced the TNF-a and IL-1b levels in peritoneal ﬂuid, whereas the IL-10 levels were
unchanged.
Conclusions: Altogether, our data conﬁrm the antinociceptive effect of TTHL and demonstrate its effect
in inﬂammatory animal models, providing novel data about this compound, which could be useful as an
anti-inﬂammatory drug.
& 2012 Published by Elsevier Ireland Ltd. Open access under the Elsevier OA license..
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Inﬂammation is a crucial and necessary function of the innate
immune system, protecting the host against pathogens and
initiating speciﬁc immunity responses. Hence, inﬂammation is ase.
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ancient times, people have been relying on plants as a prophy-
lactic or therapeutic to restore and maintain health. Plants are
well known to be an important source of many biologically active
compounds (Andrade et al., 2007), especially for the treatment of
pain and inﬂammatory diseases.
Certain species of Combretum (Combretacea) have been used in
traditional medicine to treat diseases such as pain (McGaw et al.,
2001). Combretum leprosumMart & Eich, found in the northeastern
region of Brazil, has been widely used in folk medicine. Popularly
known as mufumbo, cipoaba or mofumbo, Combretum leprosum
infusions are prepared with the aerial parts (stems, leaves and
ﬂowers) and roots and used as hemostatics and sedatives to heal
wounds during the treatment of uterine bleeding (Facundo et al.,
2005; Lira et al., 2002; Lopes et al., 2010). Chemical investigation
of this plant led to the isolation of several compounds, such as
ﬂavonoids and triterpenes (Facundo et al., 1993).
In a previous study, we demonstrated that the ethanolic
extract obtained from the ﬂowers of Combretum leprosum evoked
antinociception in several models of chemical and thermal pain in
mice (Pietrovski et al., 2006). Furthermore, we reported that the
pentacyclic triterpene 3b, 6b, 16b-trihydroxylup-20(29)-ene
(TTHL), obtained from Combretum leprosum, presents antinoci-
ceptive effects that involve the spinal glutamatergic system,
certain endogenous pain inhibitory systems, such as the opioi-
dergic (through m, k and d receptors) and serotonergic systems
(5-HT1A and 5-HT2A receptors), as well as inhibitory signaling
pathways including Gi/o protein activation and the opening of
ATP dependent-, voltage- and large-conductance Ca2þ-gated
potassium channels (Longhi-Balbinot et al., 2009, 2011).
Considering the antinociceptive effect of TTHL and the fact that
triterpenes have signiﬁcant anti-inﬂammatory activity (Andrade
et al., 2007; Costa et al., 2003; Geetha and Varalakshmi, 2001;
Hasmeda et al., 1999; Lucetti et al., 2010; Safayhi and Sailer,
1997), this study evaluated the effect of the triterpene TTHL on
nociception and vascular permeability induced by acetic acid.
We also investigated the effect of TTHL on carrageenan-induced
peritonitis and the levels of cytokines (interleukin 1-b [IL-1b],
tumor necrosis factor a [TNF-a] and interleukin 10 [IL-10]).2. Materials and methods
2.1. Animals
All experiments were performed after approval of the protocol by
the Ethics Committee for Animal Research of the Federal University
of Santa Catarina and were carried out in accordance with the
current guidelines for the care of laboratory animals and the ethical
guidelines for investigations of experimental pain in conscious
animals (Zimmermann, 1983). The experiments were conducted
using male Swiss mice (25–35 g) that were obtained from the
Federal University of Santa Catarina’s animal facility and housed at
2272 1C under a 12 h light/12 h dark cycle (lights on at 06:00 a.m.)
with access to food and water ad libitum. The mice were acclima-
tized to the laboratory for at least 1 h before testing and were used
only once throughout the experiments. The numbers of animals and
intensities of noxious stimuli used were the minimum necessary to
demonstrate consistent effects of the drug treatments.
2.2. Abdominal constriction, peritoneal capillary permeability and
leukocyte inﬁltration caused by intraperitoneal injection of acetic
acid
Abdominal constrictions were induced according to procedures
described previously (Collier et al., 1968; Lucena et al., 2007) andresulted in the contraction of the abdominal muscle along
with a stretching of the hind limbs in response to an intraperitoneal
(i.p.) injection of acetic acid (0.6%, 0.45 ml/mouse). Mice were
anesthetized by isoﬂurane inhalation (1–2%) and pre-treated
intravenously (i.v., 200 ml) with 2.5% Evans Blue Dye Solution, which
was used as a marker of capillary permeability. One hour later, the
mice received TTHL (dose range: 0.01–10 mg/kg) by intra-gastric
gavage (i.g.) 60 min prior to the acid acetic injection. In a separate
series of experiments, was investigated the effect of indomethacin
(10 mg/kg, i.p.) or dexamethasone (2 mg/kg s.c.), used as positive
controls, 30 min and 4 h before the acetic acid injection, respec-
tively. The control animals received the same volume of vehicle
(10 ml/kg, i.g.). After the challenge, the mice were placed in separate
boxes, and the number of abdominal constrictions was cumulatively
counted over a period of 20 min. Immediately after the test, the
animals were sacriﬁced by CO2 asphyxiation according to the
guidelines for the care and use of experimental animals (Heine,
1965), and their peritoneal cavity was washed with 1 ml of cold
sterile saline (NaCl 0.9%) plus heparin (25 UI/ml). After 30 s of gentle
manual massage, the exudate was retrieved. Total cell counts were
performed with a Neubauer chamber via optical microscopy, after
diluting a sample of the peritoneal ﬂuid with Tu¨rk solution (1:20).
The absorbance of the supernatant was read at 620 nm with an
ELISA analyzer. The peritoneal capillary permeability is expressed in
terms of the dye (mg/ml) that leaked into the peritoneal cavity,
according to the standard curve of the Evans blue dye (Lucena et al.,
2007; Mazzardo-Martins et al., 2010).2.3. Carrageenan-induced peritonitis (peritoneal leukocyte counts
and peritoneal capillary permeability)
Carrageenan-induced peritonitis was validated according to
procedures described previously (Montanher et al., 2007; Pagano
et al., 2002). The animals received an i.p. injection of 0.5 ml of
carrageenan (750 mg per cavity) diluted in sterile saline. At the
beginning of the experiment, the mice were anesthetized by
isoﬂurane inhalation (1–2%), and Evans blue dye solution
(25 mg/kg) was injected intravenously. One hour later, the mice
were pre-treated with TTHL (10–100 mg/kg, i.g.) or dexametha-
sone (DEXA; 0.5 mg/kg, i.p., positive control) 60 min or 30 min
before carrageenan injection, respectively. The control animals
received the same volume of vehicle (10 ml/kg, i.g.). The dose of
dexamethasone was chosen according to data in the literature
(Montanher et al., 2007) as well as based on previous studies in
our laboratory (Silva et al., 2011). Four hours after peritonitis
induction, the mice were sacriﬁced by CO2 asphyxiation and their
peritoneal cavity was washed with 1 ml of cold sterile saline
(NaCl 0.9%) plus heparin (25 UI/ml). The peritoneal ﬂuid was
collected for further analysis. Total leukocyte count and capillary
permeability were determined as described above (for more
details see Section 2.3). To determine the differential leukocyte
count, the peritoneal cells were cytocentrifuged onto slides using
a Cytospin (Tharmac, Germany) and stained with May–Gru¨wald–
Giemsa (Montanher et al., 2007; Silva et al., 2011).2.3.1. Determination of cytokines levels in the peritoneal ﬂuid
Four hours after carrageenan-induced peritonitis, peritoneal
ﬂuid samples was collected as described above and was used to
estimate the cytokine levels by enzyme-linked immunosorbent
assay (ELISA) (Mizgerd et al., 2001). Peritoneal ﬂuid aliquots of
100 ml were used to measure tumor necrosis factor alpha (TNF-a),
interleukin (IL)-1b and IL-10 levels using mouse cytokine ELISA
kits from R&D Systems (Minneapolis, MN), according to the
manufacturer’s instructions. The absorbances for all cytokines
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550 nm.
2.4. Drugs
The following substances were employed: acetic acid from
Merck (Darmstadt, Germany), carrageenan from Fluka-Biochemika
(EUA), indomethacin and Evans Blue from Sigma Chemical Co. (St.
Louis, USA) and dexamethasone (DEXA) from Ache´ Laborato´rios
Farmaceˆuticos S/A (Brazil). Cytokines levels were evaluated using
ELISA kits from R&D Systems. All drugs were dissolved in saline
solution (0.9%), except TTHL, which was dissolved in saline plus
DMSO/Tween 80, and indomethacin, which was dissolved in saline
plus DMSO. The ﬁnal concentration of DMSO and Tween 80 did
not exceed 10% and did not cause any effect per se. TTHL (Fig. 1)
was isolated from the ﬂowers of Combretum leprosum at the
Department of Organic Chemistry, Universidade Federal do Ceara´,
Brazil, as described previously (Facundo et al., 1993); its degree of
purity was 498%.
2.5. Statistical analysis
Data are presented as the means7standard error of the mean
(S.E.M.), except the ID50 values (i.e., the dose of triterpene that
reduced the abdominal constriction induced by acetic acid to 50%,
relative to the control value), which are reported as the geometric
means accompanied by their respective 95% conﬁdence limits.
The ID50 value was determined by non-linear regression from
individual experiments (GraphPad software, San Diego, CA, USA).
Comparisons between the experimental and control groups were
performed by one-way Analysis of Variance (ANOVA) followed by
Newman Keuls test when appropriate. P values less than 0.05
were considered indicative of signiﬁcance.Fig. 2. The effect of TTHL (0.01–10 mg/kg, i.g.), indomethacin (INDO, 10 mg/kg,
i.p.) or dexamethasone (DEXA, 2 mg/kg, s.c.) on acetic acid-induced abdominal
constriction (A), leukocyte inﬁltration (B), and Evans blue leakage (C) in mice.
The control group (C), black bar, indicates the mice treated by intra-gastric (i.g.)
gavage, with vehicle (DMSO/Tween 80) before acetic acid (0.6%) and the Sal group,
crosshatched bar, indicates the mice that received sterile saline (NaCl, 0.9%, i.p.).
Each column represents the mean7S.E.M. of 6 animals. The symbols nPo0.05,
nnPo0.01 and nnnPo0.001 denote the signiﬁcance level when compared to the C
group; #Po0.001 denotes the signiﬁcance level when compared to the Sal group
using a one-way ANOVA followed by the Newman–Keuls test.3. Results
3.1. Abdominal constriction, peritoneal capillary permeability and
leukocyte inﬁltration caused by intraperitoneal injection of acetic
acid
Oral administration of TTHL (0.01–10 mg/kg, i.g.) signiﬁcantly
inhibited acetic acid-induced abdominal constrictions in mice, with
a mean ID50 value (and their 95% conﬁdence limits) of 0.15 (0.03–
0.8) mg/kg and inhibition of 6973% (Po0.001; Fig. 2A). The same
dose range and similar administration of TTHL as mentioned above
also caused a marked reduction in acetic acid-induced leukocyte
inﬁltration (total cell migration), with an inhibition of 5979% at
10 mg/kg (Po0.01; Fig. 2B). On the other hand, TTHL (0.01–10 mg/
kg, i.g.) was not capable of altering abdominal capillary permeability
(Evans Blue dye exudation) induced by the injurious injection
(Fig. 2C). In addition, the positive control indomethacin (10 mg/kg,
i.p.), a non-steroidal anti-inﬂammatory drug, reduced both theFig. 1. Molecular structure of triterpene 3b, 6b, 16b-trihydroxylup-20(29)-ene
(TTHL).nociceptive behavior (9271%), total leukocyte migration (2973%)
and capillary permeability (7173%) induced by acetic acid. While
the glucocorticoid dexamethasone (2 mg/kg, s.c.), reduced partially
but signiﬁcantly the nociception (3171%), besides to promote a
marked reduction on total leukocyte migration (6072%) to the
peritoneal cavity caused by acetic acid (Fig. 2A–C).
3.2. Effect of TTHL on carrageenan-induced peritonitis in mice
The results depicted in Fig. 3A and D show that 4 h after the
injection of carrageenan, a signiﬁcant increase in both leukocyte
number and exudation occurred in the peritoneal cavity (Po0.001).
However, the number of peritoneal mononuclear cells was not
Fig. 3. The effect of pre-treatment with TTHL (10–100 mg/kg, i.g.) or dexamethasone (DEXA, 0.5 mg/kg, i.p.) on carrageenan-induced peritonitis in mice. (A) Total
leukocytes, (B) neutrophils, (C) mononuclear cells and (D) Evans blue leakage (exudation). The carrageenan group (Cg), black bar, indicates the mice treated by intra-gastric
(i.g.) gavage, with vehicle (DMSO/Tween 80) before carrageenan (750 mg/cavity) and the Sal group, crosshatched bar, indicates the mice that received sterile saline
(NaCl, 0.9%, i.p.). Each column represents the mean of 6 animals. The symbols nnnPo0.001 and #Po0.001 denote the signiﬁcance level when compared to the Cg group or
Sal group, respectively, using a one-way ANOVA followed by the Newman–Keuls test.
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i.g. 1 h prior to carrageenan injection promoted signiﬁcant inhibition
of the inﬂammatory process, with a marked decrease in total
leukocyte migration (maximal inhibition of 6474% at 30 mg/kg)
(Po0.001; Fig. 3A). Leukocytes that migrated into the peritoneal
cavity 4 h after injection of carrageenan were mainly neutrophils, as
observed microscopically in the peritoneal ﬂuid lamina. Here, we
demonstrated that TTHL also decreased the number of neutrophils,
with inhibitions of 8473% and 8572% at doses of 30 mg/kg and
100 mg/kg, respectively (Po0.001; Fig. 3B). The treatment of mice
with the steroidal anti-inﬂammatory drug dexamethasone (DEXA;
0.5 mg/kg, i.p.) also decreased total cell migration by 9373%,
represented mainly by an inﬂux of neutrophils (Po0.001; Fig. 3A
and B). Carrageenan-induced peritoneal inﬂammation was accom-
panied by an increase in the abdominal vascular permeability,
observed by Evans blue dye exudation. We observed that only a
systemic DEXA treatment reduced Evans blue extravasation
(Po0.001), while TTHL did not alter the carrageenan-induced
abdominal vascular permeability (Fig. 3C).
3.3. Effects of TTHL on TNF-a, IL-1b and IL-10 levels
Four hours after carrageenan injection, the TNF-a and IL-1b
levels signiﬁcantly increased, while IL-10 levels decreased
(Po0.001; Fig. 4A–C). Furthermore, the treatment of the animals
with DEXA (0.5 mg/kg, i.p.) or TTHL (30 mg/kg) signiﬁcantly
reduced the TNF-a and IL-1b levels in the peritoneal ﬂuid
(Po0.001; Fig. 4A and B), respectively, whereas IL-10 levels were
unchanged (Fig. 4C).4. Discussion
A number of plants used in folk medicine exhibit pharmacolo-
gical properties, mainly related to anti-inﬂammatory activities, and
have great phytotherapeutic potential. The present study showed
that the i.g. administration of TTHL, a triterpene isolated from
Combretum leprosum, inhibits acetic acid-induced viscerosomaticnociception and cellular migration. In addition, TTHL presented an
anti-inﬂammatory activity and, at the same time, reduced leuko-
cyte migration and carrageenan-induced cytokine release, namely
tumor necrosis factor a (TNF-a) and interleukin-1b (IL-1b).
It has been established that the peritoneal injection of acetic
acid promotes the release of many endogenous inﬂammatory
mediators by mast cells and macrophages that reside in the
peritoneal cavity, such as kinins, prostanoids, nitric oxide, sub-
stance P, TNF-a and IL-1b (Collier et al., 1968; Ikeda et al., 2001;
Ribeiro et al., 2000; Vinegar et al., 1979). Moreover, these
mediators are able to produce not only nociception but an
increase in vascular permeability and leukocyte migration, which
are three important features of the inﬂammatory process (Lucena
et al., 2007; Smiderle et al., 2008; Zeashan et al., 2009).
In the present study, we showed that TTHL inhibited leukocyte
migration and nociception induced by i.p. acetic acid injection,
although it was not able to alter abdominal capillary permeability
(Evans blue leakage) which results from an inﬂammatory exuda-
tive reaction in the peritoneal cavity (Smiderle et al., 2008).
Taking the literature data and the results presented here into
account, the antinociceptive and anti-inﬂammatory actions of
Combretum leprosum-derived TTHL in the acetic acid abdominal
constriction test might be due to an inhibition in the release of
endogenous inﬂammatory mediators by resident peritoneal cells.
There are evidences showing that inﬂammation and/or tissue
damage can induce the release of glutamate from primary
afferents, enhancing the activation of excitatory amino acid
receptors in the peripheral tissue (Carlton, 2001; Hoffman and
Miller, 2010; Miller et al., 2011; Sluka and Westlund, 1992). The
activation of glutamate NMDA receptors causes the secretion of
inﬂammatory mediators, i.e., TNF-a and IL-1b, that in turn can
sensitize peripheral nerve endings and activate the immune
response (Kane et al., 2005; McNearney et al., 2010; Sweeney
and Firestein, 2004; Zelenka et al., 2005). Additionally, Feng et al.
(2003) found an increase in the concentration of glutamate and
aspartate in the cerebrospinal ﬂuid after i.p. injection of acetic
acid. Based on our present and previous results (Longhi-Balbinot
et al., 2009, 2011), as well as corroborating literature data, it
Fig. 4. The effects of TTHL (30 mg/kg, i.g.) or dexamethasone (DEXA; 0.5 mg/kg, i.p.)
on TNF-a (A), IL-1b (B) and IL-10 production (C) in mice with carrageenan-induced
peritonitis. The carrageenan group (Cg), black bar, indicates the mice treated by
intra-gastric (i.g.) gavage, with vehicle (DMSO/Tween 80) before carrageenan
(750 mg/cavity) and the Sal group, crosshatched bar, indicates the mice that
received sterile saline (NaCl, 0.9%, i.p.). Each column represents the mean of
6 animals. The symbols nnnPo0.001 and #Po0.001 denote the signiﬁcance level
when compared to the Cg group or Sal group, respectively, using a one-way ANOVA
followed by the Newman–Keuls test.
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inﬂammatory effects by inhibiting the excitatory effect of the
glutamatergic system during the promotion and maintenance of
pain states and inﬂammatory events.
Given the signiﬁcant effects evoked by TTHL and the involve-
ment of glutamate on inﬂammatory pain models, we investigated
the effect of triterpene on carrageenan-induced inﬂammation to
conﬁrm the anti-inﬂammatory activity of TTHL.
Carrageenan-induced peritonitis is a well-characterized experi-
mental model of acute inﬂammation, largely employed to test new
anti-inﬂammatory therapies, which allow researchers to quantify
or analyze peritoneal vascular permeability and cellular migration
as well as changes in other inﬂammatory parameters, such as
cytokine production (Beekhuizen and Van Furth, 1993; Downey
et al., 1995; Silva et al., 2011). Thus, in our study, it was possible to
produce an acute inﬂammatory response in the peritoneal cavity ofmice four hours after carrageenan injection. This resulted in a
gradual enhancement in ﬂuid leakage and in the total number of
cells that migrated into the peritoneal cavity, represented mainly
by neutrophil inﬂux.
Neutrophils are the main leukocyte subtype participating in
organism defense, and their migration from blood vessels into the
tissue is a crucial process during host response against micro-
organism infections/injurious agents (Malech and Gallin, 1987).
Although they have a protective role in inﬂammation, tissue
damage is a deleterious consequence of the intense migration of
neutrophils, as observed in immune inﬂammatory diseases (Jones
et al., 1991; Smiderle et al., 2008). In the present study, we
conﬁrm the anti-inﬂammatory effect of triterpene, as i.g. treat-
ment of the animals with TTHL signiﬁcantly decreased total
leukocyte migration, predominantly of neutrophils, four hours
after peritonitis induction. However, the TTHL treatment was not
able to decrease the abdominal vascular permeability induced by
carrageenan. These ﬁndings corroborate previous studies demon-
strating that the anti-inﬂammatory effect is a common property
of many triterpenoids (Andrade et al., 2007; Costa et al., 2003;
Geetha and Varalakshmi, 2001; Hasmeda et al., 1999; Safayhi and
Sailer, 1997).
It has been clearly established that leukocytes, among other
cells, are a source of pro-inﬂammatory cytokines, i.e., TNF-a and
IL-1b, released during the acute inﬂammation induced by carra-
geenan (Pereira et al., 2006; Silva et al., 2011). There is evidence
that these pro-inﬂammatory cytokines help to propagate the
extension of a local or systemic inﬂammatory process (Mizgerd
et al., 2001). In relation to the involvement of TNF-a and IL-1b in
the carrageenan-induced peritonitis model, we demonstrated
that TTHL signiﬁcantly reduced the levels of these pro-inﬂam-
matory cytokines in the peritoneal ﬂuid of carrageenan-injected
mice. Therefore, the inhibitory effect of TTHL upon leukocyte
inﬂux induced by carrageenan in the mouse peritoneal cavity
demonstrated herein could be attributed to the suppression of
the release of pro-inﬂammatory cytokines such as TNF-a and IL-
1b, i.e., by inhibiting the activation of the glutamatergic system.
However, additional studies are necessary to conﬁrm this
hypothesis.
In summary, the present study showed that the pentacyclic
triterpene TTHL elicited signiﬁcant antinociceptive and anti-
inﬂammatory effects in a mouse model of visceral nociception
induced by acetic acid and peritonitis caused by carrageenan.
These ﬁndings provide experimental evidence for the traditional
use of Combretum leprosum in treating several diseases associated
with inﬂammation and pain and suggest that TTHL could repre-
sent a therapeutically novel compound useful for their clinical
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